Aurora Cannabis (NASDAQ:ACB - Get Free Report) will likely be releasing its earnings data before the market opens on Thursday, February 13th. Analysts expect Aurora Cannabis to post earnings of $0.04 per share for the quarter. Parties interested in participating in the company's conference call can do so using this link.
Aurora Cannabis (NASDAQ:ACB - Get Free Report) last posted its earnings results on Wednesday, February 5th. The company reported $0.06 EPS for the quarter, topping the consensus estimate of ($0.09) by $0.15. Aurora Cannabis had a net margin of 0.42% and a return on equity of 0.59%. On average, analysts expect Aurora Cannabis to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.
Aurora Cannabis Trading Down 3.5 %
NASDAQ ACB traded down $0.22 on Friday, hitting $6.03. The company's stock had a trading volume of 8,729,844 shares, compared to its average volume of 5,163,835. The company's 50-day moving average is $4.27 and its 200 day moving average is $5.15. The firm has a market cap of $330.81 million, a PE ratio of 120.62 and a beta of 1.84. Aurora Cannabis has a 1-year low of $2.84 and a 1-year high of $9.35. The company has a quick ratio of 1.88, a current ratio of 3.30 and a debt-to-equity ratio of 0.07.
Analyst Upgrades and Downgrades
ACB has been the subject of several analyst reports. Atb Cap Markets raised Aurora Cannabis from a "hold" rating to a "strong-buy" rating in a research report on Wednesday. TD Securities raised Aurora Cannabis to a "strong-buy" rating in a research note on Thursday, December 12th. Finally, TD Cowen assumed coverage on Aurora Cannabis in a report on Wednesday, December 11th. They issued a "buy" rating on the stock.
Check Out Our Latest Stock Analysis on Aurora Cannabis
Aurora Cannabis Company Profile
(
Get Free Report)
Aurora Cannabis Inc, together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada.
Featured Articles
Before you consider Aurora Cannabis, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aurora Cannabis wasn't on the list.
While Aurora Cannabis currently has a "Strong Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
